Premium
Quercus Suber L. Cork Extracts Induce Apoptosis in Human Myeloid Leukaemia HL‐60 Cells
Author(s) -
Bejarano Ignacio,
GodoyCancho Belén,
Franco Lourdes,
MartínezCañas Manuel A.,
Tormo María A.
Publication year - 2015
Publication title -
phytotherapy research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.019
H-Index - 129
eISSN - 1099-1573
pISSN - 0951-418X
DOI - 10.1002/ptr.5364
Subject(s) - quercus suber , cork , apoptosis , biology , programmed cell death , cancer cell , cytotoxicity , phosphatidylserine , traditional medicine , biochemistry , chemistry , botany , cancer , membrane , in vitro , medicine , phospholipid , genetics
Quercus suber L. cork contains a diversity of phenolic compounds, mostly low molecular weight phenols. A rising number of reports support with convergent findings that polyphenols evoke pro‐apoptotic events in cancerous cells. However, the literature related to the anti‐cancer bioactivity of Q. suber L. cork extractives (QSE) is still limited. Herein, we aim to describe the antitumor potential displayed by cork extractives obtained by different extraction methods in the human promyelocytic leukaemia cells. In order to quantify the effects of QSE on cancer cells viability, phosphatidylserine exposure, caspase‐3 activity, mitochondrial membrane potential and cell cycle were evaluated. The results indicated that the QSE present a time‐dependent and dose‐dependent cytotoxicity in the human promyelocytic leukaemia cells. Such a noxious effect leads these leukaemia cells to their death through apoptotic processes by altering the mitochondrial outer membrane potential, activating caspase‐3 and externalizing phosphatidylserine. However, cells cycle progression was not affected by the treatments. This study contributes to open a new way to use this natural resource by exploiting its anti‐cancer properties. Moreover, it opens new possibilities of application of cork by‐products, being more efficient in the sector of cork‐based agriculture. Copyright © 2015 John Wiley & Sons, Ltd.